OXCARBAZEPINE EXTENDED RELEASE TABLETS

Clinical safety rating: caution

Strong CYP3A4 inducers may decrease levels of active metabolite Can cause hyponatremia and cross-hypersensitivity with carbamazepine.

How it works

Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.

Tablet 300 mg - Oral

Dosage form	TABLET
Renal impairment	Consult protocols for adjustment.
Liver impairment	Consult protocols for adjustment.

Clinical note

Strong CYP3A4 inducers may decrease levels of active metabolite Can cause hyponatremia and cross-hypersensitivity with carbamazepine.

FDA category

Category Animal

diplopia

Loading safety data…

Clinical safety rating: caution

Strong CYP3A4 inducers may decrease levels of active metabolite Can cause hyponatremia and cross-hypersensitivity with carbamazepine.

Mechanism information is still being processed. Check the DailyMed link in the sidebar for the official prescribing information.

Tablet 300 mg - Oral

Dosage form	TABLET
Renal impairment	Consult protocols for adjustment.
Liver impairment	Consult protocols for adjustment.

Clinical note

Strong CYP3A4 inducers may decrease levels of active metabolite Can cause hyponatremia and cross-hypersensitivity with carbamazepine.

FDA category

Category Animal

diplopia

Loading safety data…